Hormone therapy in transgender women may deteriorate cardiovascular health

Hormone treatment given to transgender patients transitioning from male to female may significantly increase their risk of stroke, a study inAnnals of Internal Medicine reports. Reuters
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

Researchers at Kaiser Permanente and Emory University studied 100,000 people for the first ever study on the risk of hormone therapy in transgender men and women.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
TUESDAY, July 10, 2018 -- Transwomen who undergo hormone therapy may face higher chances of blood clots, stroke and heart attack, a new study suggests. The term transwoman refers to a woman who is designated male at birth. Some undergo hormone...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Conclusion: The patterns of increases in VTE and ischemic stroke rates among transfeminine persons are not consistent with those observed in cisgender women. These results may indicate the need for long-term vigilance in identifying vascular side effects of cross-sex estrogen. Primary Funding Source: Patient-Centered Outcomes Research Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development. PMID: 29987313 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Tags: Ann Intern Med Source Type: research
Researchers at Kaiser Permanente and Emory University studied 100,000 people for the first ever study on the risk of hormone therapy in transgender men and women.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
(Reuters Health) - Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women, one of the largest studies of transgender patients has concluded.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
According to this study: Optimal stroke prevention strategies for women should take into account risk factors specific to women, including endogenous hormone levels, exogenous hormone therapy, and pregnancy-related complications.
Source: AJN - Category: Nursing Tags: Journal Watch Source Type: research
CONCLUSION: Our study shows a very low report of cardiovascular effects under testosterone, all doubtful. Pending further studies, it seems reasonable to consider the cardiovascular risk of patients who are candidates for hormone therapy for age-related androgen deficiency. LEVEL OF EVIDENCE: 3. PMID: 29650456 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
Conclusions: Discontinuation of postmenopausal HT may be associated with increased risk of cardiac and stroke death in the first posttreatment year. Further investigation is required to evaluate causality of the observed associations.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusion We found that combined use of HT and CHM was associated with a lower risk of IS. Further study is needed to examine possible mechanism underlying this association. Graphical abstract
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
No abstract available
Source: Neurology Today - Category: Neurology Tags: Features Source Type: research
More News: Cardiology | Cardiovascular | Endocrinology | Heart | Hormonal Therapy | Hormones | Internal Medicine | Stroke | Study | Women